Treiber, Michelle

Jason Kropp is a partner in the Corporate Practice Group. He joined the firm in 2002. Mr. Kropp practices corporate and securities law, with an emphasis on public offerings and public company representation, and representation of venture-backed companies and venture capital investors.

Practice

A significant portion of Mr. Kropp's practice consists of counseling public companies on ongoing corporate legal matters, including federal securities reporting requirements and corporate governance issues. He has represented issuers and underwriters in capital markets financings. His public offering experience includes initial public offerings, follow-on equity offerings and convertible debt offerings. Mr. Kropp also advises early stage private companies on formation and financing issues and equity and compensation matters. His venture capital experience includes representing investors and issuers in initial- and late-stage venture capital financings. In addition, Mr. Kropp has represented public and private companies in mergers and acquisitions, including acquisitions of both public and private companies by public companies and financial buyers.

Prior to attending law school, Mr. Kropp worked as a legislative and press aide in the office of United States Representative William Delahunt, and as a legislative intern in the office of United States Representative Gerry Studds.

Practice Highlights

Representation of:

• Ameresco, Accretive Health, LogMeIn, Cynosure and Eyetech Pharmaceuticals in their initial public offerings
• Millennium Pharmaceuticals in its $8.8 billion acquisition by Takeda Pharmaceuticals
• EqualLogic in “dual track” IPO/sale, resulting in $1.4 billion acquisition by Dell—then the largest cash purchase price in history for a private VC-backed company
• Novartis Venture Fund, General Catalyst Partners and New Leaf Venture Partners in new and portfolio company investments
• Deutsche Bank Securities as lead underwriter in the initial public offering of Targacept, Inc.
• Amdocs Limited, LIN TV Corp. and Lincare Holdings in 144A offerings of convertible notes
• Morgan Stanley as lead underwriter in follow-on public offering of common stock by Barrier Therapeutics, Inc.
• Lucent Technologies Inc. in its acquisition of assets of Riverstone Networks, Inc.; DoubleClick in its acquisition by Hellman & Friedman; Amdocs Limited in its acquisitions of Qpass Inc. and DST Innovis from DST Systems, Inc.  
• DC Devices, Blackwave, Intercept Pharmaceuticals, Partsearch Technologies, Evident Software, and other private companies in various venture capital financings

Community Involvement

Mr. Kropp represents pro bono client, Grist.org, an online environmental news and opinion magazine. He is also a member of the Board of Visitors of the Walnut Hill School in Natick, Massachusetts.

Honors and Awards

• Recognized as a 2011 "Up & Coming Lawyer" by Massachusetts Lawyers Weekly

Speaking Engagements

• Trading in Private Company Shares: Securities Law Considerations – Boston Bar Association, Securities Law Subcommittee Brown Bag Lunch Series, September 2011
• Public Company Fundraising: A Beginner’s Guide to Follow-Ons, PIPEs and 144As – Boston Bar Association, Securities Law Subcommittee Brown Bag Lunch Series, May 2010
• Corporate Practice Basics: Overview of Registration and Reporting Requirements of the Federal Securities Laws – Massachusetts Continuing Legal Education, 2009-2011